Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update appears to be a system/UI refresh and does not modify study details, eligibility criteria, or results.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedThe study status is updated to terminated due to financial hardships, and results have been posted with dates and linked documents. The prior Active, not recruiting status and earlier submission notes were removed.SummaryDifference2%

- Check64 days agoChange DetectedRevision tag updated to v3.4.2 is now shown. The lapse-in-government-funding notice and the prior Revision: v3.4.1 text were removed.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for updates while noting the NIH Clinical Center is open. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedUI/metadata updates include a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' label, and revision/version information in the footer, plus capitalization tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.